Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplastic Cells, Circulating 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 25Reverse Transcriptase Polymerase Chain Reaction 7Flow Cytometry 7Liquid Biopsy 4cabazitaxel 3Surgical Procedures, Operative 3Propofol 3Carboplatin 3Bevacizumab 3Trastuzumab 2Spinal Puncture 2Sevoflurane 2Positron Emission Tomography Computed Tomography 2Pirinitramide 2Neoadjuvant Therapy 2Morphine 2Laparoscopy 2Hematologic Tests 2Folfox protocol 2Epirubicin 2Drug Therapy 2Docetaxel 2Cyclophosphamide 2Cisplatin 2Cetuximab 2Capecitabine 2Aspirin 2Anesthesia, General 2ribociclib 1pertuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplastic Cells, Circulating × jinfukang × Clear all
NCT02603003 2019-09-20

CTC-TCM-FZ

Shanghai University of Traditional Chinese Medicine

Phase 1 Completed
218 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡